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Summary
Giant cell tumor, excluding its prototype in bone, is usually a benign but local aggressive neoplasm
originating from tendon sheath or soft tissue. Malignant behavior is uncommon. Visceral organ
involvement including urinary bladder is rare. Giant cell tumors in visceral organs usually
accompany epithelial tumors and the clinical behavior of giant cell tumor in urinary bladder is similar
to its bone counterpart. Here, we report two cases of giant cell tumor located in urinary bladder
in comparison with nine reported cases in the English literature. Concurrent noninvasive urothelial
carcinoma was also described in all these previous reports and only one patient with follow-up died
of disease. One of the two cases we present had no concurrent urothelial tumor at the time of
diagnosis but had a history of a low grade noninvasive urothelial carcinoma with three recurrences.
The histology of these two cases was similar to the giant cell tumor of bone and composed of oval
to spindle mononuclear cells with evenly spaced osteoclast-like giant cells. Immunohistochemically,
the giant cells showed staining with osteoclastic markers including CD68, TRAP, and LCA.
Immunohistochemical expression of vimentin, CD68, LCA, and smooth muscle actin in
mononuclear cells supported a mesenchymal origin with histiocytic lineage. The histologic and
immunohistochemical properties in our cases as well as their clinical courses were consistent with
a giant cell tumor. Consequently, tumors in urinary bladder showing features of giant cell tumor of
bone may also be considered and termed "giant cell tumor".
Introduction
Giant cell tumor (GCT) usually originates from bone, ten-
don sheath or soft tissue and is composed of oval, plump
mononuclear cells and osteoclasts with a slow rate of
growth and low incidence of malignant behavior. Tumors
with similar histology were described in a variety of vis-
ceral organs such as pancreas, ovary, larynx, urinary tract,
thyroid and salivary glands [1-6]. The etiology and his-
togenesis of GCT are controversial and have largely
remained unexplained. GCT is exceptionally rare in uri-
nary bladder with only nine cases reported in English lit-
erature to date [7-12]. GCT is usually accompanied by an
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epithelial neoplasm in visceral organs including the uri-
nary bladder.
Holtz et al. was the first to describe GCT in urinary bladder
and since then it has been referred to by various names
such as carcinosarcoma, GCT, giant cell reparative granu-
loma, osteoclast-like GCT, and osteoclast-rich undifferen-
tiated carcinoma [7-10,12]. Recent reports suggest that
tumors in visceral organs such as urinary bladder and pan-
creas should be classified in the undifferentiated carci-
noma group considering the common accompaniment of
epithelial neoplasms, as well as immunohistochemical
expression of epithelial markers and p53, and aggressive
course in some cases [12,13]. On the other hand, except
from high grade or invasive neoplasms GCT-like lesions
may also accompany to those with benign or non-invasive
low grade histology or even arise de novo. In addition de
novo tumors as well as some soft tissue tumors may also
express epithelial markers immunohistochemically. These
findings indicate that histogenesis of GCT is still contro-
versial and that at least some lesions may be an overdiag-
nosed as "undifferentiated carcinoma".
In this study, we evaluated the clinical, histologic and
immunohistochemical findings in two cases of urinary
bladder tumors having morphological findings similar to
GCT of bone, compared them with previous cases
reported in English literature, and discussed the histogen-
esis and nomenclature of GCT.
Case Reports
Clinical Histories
Case 1. Cystoscopic examination of a 56 year old man pre-
sented with hematuria in March 2003 revealed a 1 cm
mass at the posterior wall of urinary bladder. The patho-
logic diagnosis was noninvasive low grade urothelial car-
cinoma. Tumor recurrences were seen at cystoscopic
controls in August 2003, March 2004 and August 2004.
The histologic appearances of the recurrences were identi-
cal to the first tumor. In June 2005, the patient had an
additional cystoscopic examination due to severe painful
hematuria. An ulcerated mass located at lateral wall and
trigone was resected transurethrally and sent for patho-
logic examination. No other lesions were detected by clin-
ical and radiological examinations of the whole body. He
has been free of disease for 43 months.
Case 2. The second case was a 74 year old man presented
with severe hematuria. Cystoscopy was performed and
biopsy was taken. The patient has been free of disease for
50 months.
Materials and methods
The English literature was scanned and nine cases of GCT
of urinary bladder were found. The primary diagnosis of
our cases belongs to KB and HD, respectively. Clinical his-
tories of the patients were obtained from clinical files. All
hematoxylin-eosin stained slides were examined and the
most representative slides were chosen for immunohisto-
cemical examination. Immunohistochemistry was per-
formed using the standardized streptavidin-biotin-
immunoperoxidase complex with 3'3' diaminobenzidine
as chromogen (large volume DAKO, Carpenteria, CA,
USA) LSAP+ kit, according to the manufacturer's instruc-
tions. Specifications for the various immunostains that
were used are listed in Table 1.
Results
Pathologic Findings
At light microscopy, both tumors displayed the typical
morphological properties of GCT of bone composed of
mononuclear and multinucleated giant cells (osteoclasts)
forming clusters and nodules. Mononuclear cells were
oval, plump or spindle with scant eosinophilic cytoplasm
(Figure 1, 2). Mitoses in mononuclear cells (1-2/10 HPF)
were present only in Case 1. Cytological atypia and pleo-
morphism in mononuclear cells were minimal in both
cases. Rich vascularized stroma with extravasated erythro-
cytes and lakes filled with blood were also noted. Giant
cells morphologically similar to osteoclasts clustered
mostly in hemorrhagic areas. Giant cells had up to 40
nuclei with bi- or tri-nucleated variants. There were no
mitoses in giant cells in either case.
In Case 1, there was extensive ulceration and regenerative
changes in the surface epithelium. Despite the history of
three previous recurrences of low grade noninvasive
urothelial carcinoma there was no urothelial neoplasia in
the present material. The tumor revealed an infiltrative
growth pattern but there was no lymphovascular inva-
sion.
In Case 2, low grade noninvasive urothelial carcinoma
was noted in the surface epithelium. GCT was localized
beneath the urothelial tumor in the lamina propria and
had a nodular infiltrative growth pattern without lym-
phovascular invasion (Figure 3).
Immuohistochemical Findings
Immunohistochemically mononuclear cells in both
tumors stained positive with vimentin and CD68. In case
1, there was also focal a-SMA positivity. Ki-67 proliferative
index was 5-10% and 2% in the first and second cases,
respectively. Less than 10% of mononuclear cells exhib-
ited p53 expression. Giant cells showed vimentin expres-
sion, strong cytoplasmic and membranous staining with
LCA, and cytoplasmic staining with TRAP (Figure 4) and
CD68. Neither mononuclear cells nor giant cells immu-
nohistochemically expressed epithelial markers in both
cases.Diagnostic Pathology 2009, 4:48 http://www.diagnosticpathology.org/content/4/1/48
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Table 1: List of Antibodies for Immunohistochemical Studies
Antibody Clone Dilution Antigen retrieval method Source
Vimentin V9 1:150 Citrate buffer (20 min) Neomarkers, Fremont, CA, USA
Epithelial membrane antigen (EMA) GP1.1 1:150 Citrate buffer (20 min) DBS, Pleasanton, CA
Pan-cytokeratin AE1/AE3 1:50 Citrate buffer (20 min) Neomarkers
Cytokeratin 7 OV-TL 12/30 1:200 Tripsin (10 min at 37°C) Neomarkers
Cytokeratin 20 Ks20.8 1:100 Tripsin (10 min at 37°C) Neomarkers
Desmin D33 1:100 Citrate buffer (20 min) Neomarkers
α-Actin (SMA) 1A4 1:200 Citrate buffer (20 min) Neomarkers
S-100 protein 4C4.9 1:150 Citrate buffer (20 min) Neomarkers
Leukocyte common antigen (LCA) Cocktail PanLCA 1:200 Citrate buffer (20 min) Neomarkers
CD68 PG-M1 1:100 Citrate buffer (20 min) Neomarkers
Ki-67 SP6 1:200 Citrate buffer (20 min) Neomarkers
P53 DO7 Prediluted Citrate buffer (20 min) Dako, Carpenteria, CA, USA
TRAP 26E5 Prediluted Citrate buffer (20 min) Neomarkers
Numerous osteoclasts (arrow) and few mononuclear cells  between blood lakes in Case 2. (H&E, × 300) Figure 1
Numerous osteoclasts (arrow) and few mononuclear 
cells between blood lakes in Case 2. (H&E, × 300).
Spindled mononuclear cells and dispersed osteoclasts in Case  1. (H&E, × 200) Figure 2
Spindled mononuclear cells and dispersed osteo-
clasts in Case 1. (H&E, × 200).Diagnostic Pathology 2009, 4:48 http://www.diagnosticpathology.org/content/4/1/48
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Discussion
GCT with its typical biphasic histologic feature including
mononuclear cells and osteoclastic cells may be seen in
different localizations and described under a variety of
names such as giant cell tumor of bone, giant cell tumor
of soft tissue, reparative granuloma, giant cell tumor of
tendon sheath (local and diffuse), and giant cell tumor in
visceral organs.
GCT arising in visceral organs is uncommon and it is
extremely rare in urinary tract with only 9 cases in urinary
bladder reported in literature to date (Table 2). The termi-
nology and histogenesis of the GCT in visceral organs is
still unclear and somewhat controversial. Tumors local-
ized in urinary bladder and pancreas have been named as
osteoclast-rich undifferentiated carcinoma in the recently
published reports [12,13]. The presence of a synchronous
epithelial tumor in most of the cases, as well as immuno-
histochemical expression of p53 and some epithelial
markers in mononuclear cell component, and aggressive
clinical behavior were the main reasons for the nomencla-
ture used in various organs.
Kitazawa et al was the first to describe urothelial carci-
noma having the morphology of "giant cell tumor of the
bone". Since then nine similar cases have been reported to
date. In the single case by Kitazawa et al and the other two
cases by Amir and Rosenmann, non-invasive low-grade
papillary carcinomas accompanied giant cell tumors with-
out any direct connection between two tumor compo-
nents or any other additional morphologic findings that
may suggest a form of neoplastic transformation. They
also concluded that morphological features in these cases
were similar to those of giant cell tumor of the bone and/
or reparative granuloma. Additionally, as invasion is an
unexpected feature in low-grade carcinoma and giant cell
tumor in these tumors are apparently located beneath the
neoplastic or nonneoplastic epithelium one can easily
propose that these tumors (i.e. low-grade carcinoma and
giant cell tumor) represent two distinct entities rather
than a transformation from one. Holtz et al, in 1972, first
employed the term carcinosarcoma in their report of a
case similar to that of Kitazawa et al. The patient survived
for 33 months and died because of another cause. Baydar
et al reported that one of the three such cases died. Only
one of the 11 reported patients including our two cases
died due to the disease. This is also consistent with the
concept that aggressive behavior might be expected in
conventional giant-cell tumor. Furthermore giant cell
tumor of bone-like morphology is not a usual pattern in
anaplastic-pleomorphic carcinoma.
The tumors in our both cases were histopathologically
similar to osteoclastic giant cell tumor of bone and soft
tissue. They were composed of round, oval and occasion-
ally spindle shaped mononuclear cells and osteoclastic
giant cells. Mononuclear cells in both tumors displayed
minimal pleomorphism. Few mitoses (1-2/10 HPF) were
noted in Case 1 which had an extensive surface ulceration.
Osteoclastic cells were primarily seen within the area of
oval to round mononuclear cells rather than spindle
mononuclear cells. Moreover, these cells had a tendency
to concentrate around areas with extravasated erythro-
cytes. Tumors also had a rich vasculature. Despite the his-
tory of relapsing urothelial carcinoma in Case 1 there was
a nontumoral surface epithelium with no foci of an
urothelial tumor. On the other hand, noninvasive low
grade urothelial carcinoma was seen in Case 2. Immuno-
Low grade urothelial carcinoma (arrow) and giant cell tumor  in Case 2. (H&E, × 100) Figure 3
Low grade urothelial carcinoma (arrow) and giant 
cell tumor in Case 2. (H&E, × 100).
Giant cells showing cytoplasmic staining with TRAP (arrow)  in Case 1 Figure 4
Giant cells showing cytoplasmic staining with TRAP 
(arrow) in Case 1.Diagnostic Pathology 2009, 4:48 http://www.diagnosticpathology.org/content/4/1/48
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histochemically, mononuclear cells expressed vimentin
and histiocytic marker CD68. Giant cells expressed
vimentin, TRAP, LCA and CD 68 pointing out a mesen-
chymal lineage. The exact nature of both osseous and
extraosseous osteoclastic giant cell tumors is still contro-
versial although many cells of origin -including undiffer-
entiated mesenchymal, monohistiocytic, endothelial,
reticuloendothelial and epithelial- have been suggested
for extraosseous GCT. One of the most important and
consistent features of GCT in urinary bladder is its fre-
quent association with an epithelial neoplasia. In addi-
tion, immunohistochemical expression of p53 and some
epithelial markers in GCT is also noteworthy. These fea-
tures led some authors such as Baydar et al to describe
these tumors as 'osteoclast-rich undifferentiated carci-
noma' [12]. Similar terms including 'undifferentiated car-
cinoma with osteoclast-like cells' and 'osteoclast-type
giant cell carcinoma' were also used for tumors in pan-
creas and salivary glands, respectively [13,14].
Nearly half of the extraosseous giant cell tumors express at
least one or two epithelial markers immunohistochemi-
cally. Additionally, mononuclear cells in most of these
tumors also express histiocytic markers and vimentin,
similar to 'de novo' GCT not accompanied by epithelial
tumors [4,15,16]. Therefore, it may be assumed that mor-
phological features of mononuclear cells in GCT as well as
features suggesting a histiocytic lineage are similar in both
soft tissue and visceral tumors. Osteoblastic differentia-
tion is prominent in bone whereas synovial features are
more pronounced in tendons [17,18]. In any circum-
stances, all GCTs have a common morphology and low
degree of aggressiveness. In addition, p53 expression can
be seen not only in GCT of visceral organs but also of
bone, and the malignant form of GCT of bone has been
presented as a new entity in the recent WHO classification
[19-21].
The term 'undifferentiated carcinoma' should be reserved
for the tumors mainly composed anaplastic carcinoma
cells (spindle cells, pleomorphic giant cells or bizarre
cells). Osteoclasts may also be seen in carcinomas of vis-
ceral organs, gastrointestinal stromal tumors and leiomy-
osarcomas [22-24]. These tumors should be clearly
Table 2: Literature Review of Giant Cell Tumor of Urinary Bladder
Authors Age/sex Expression of 
histiosytic markers 
and vimentin in MC
Expression of 
epithelial 
markers in MC
Associated 
malignancies
Treatment Outcome
Holtz et al [7] 79/M NA NA UC TUR Death at 33 months 
(unrelated cause)
Kitazawa et al [8] 67/M NA NA UC, noninvasive TUR NED (8 months)
Ligdi et al [9] 67/F NA Keratin (-)
EMA (-)
UC, noninvasive TUR NED (18 months)
Amir and 
Rosermann [10]
74/M Vimentin (+) Keratin (-)
EMA (-)
UC, noninvasive NA NA
69/M Vimentin (+) Keratin (-)
EMA (-)
UC, noninvasive NA NA
O'Conner et al [11] 73/F NA NA None TUR,
Anterior pelvic
Exenteration+
vaginectomy
Baydar et al [12] 81/M CD68 (+) Keratin (-)
EMA (-)
UC, noninvasive TUR NA
81/M CD68 (+) Keratin (-)
EMA (-)
UC, noninvasive TUR Alive, recurrent UC 
(4 months)
67/M CD68 (+) Keratin (-)
EMA (+)
UC, noninvasive Radical cystectomy Death at 1 year
Behzatoglu et al
(New cases)
56/M CD68 (+)
Vimentin (+)
SMA (+)
Keratin (-)
EMA (-)
None TUR NED (35 months)
74/M CD68 (+)
Vimentin (+)
Keratin (-)
EMA (-)
UC, noninvasive TUR NED (42 months)
UC, urothelial carcinoma; NED, no evidence of disease; NA, not available; MC, mononuclear cellsDiagnostic Pathology 2009, 4:48 http://www.diagnosticpathology.org/content/4/1/48
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differentiated from tumors with typical morphological
features of GCT accompanying to an in situ or invasive
carcinoma to prevent an overdiagnosis of 'undifferenti-
ated carcinoma'.
The prognosis of pure 'de novo' GCT in visceral organs is
similar to their bone counterparts and aggressive behavior
is very rare, thus total excision is an adequate treatment
choice. Immunohistochemical expression of keratins is a
common feature both in 'de novo' tumors and in tumors
accompanying an epithelial tumor. GCT is expected to be
seen 'de novo' in visceral organs similar to other mesen-
chymal tumors located in organs other than bone and soft
tissue. However, simultaneous presence of epithelial
tumor whether benign or malignant is still a subject of
controversy causing a diagnostic challenge. A common
carcinogen affecting both epithelial and stromal cells may
be a possible explanation.
We believe that tumors in urinary bladder exhibiting mor-
phologic features similar to GCT of bone should be eval-
uated separately from the accompanying epithelial
tumors, if any, and should be designated as 'giant cell
tumor' due to their favorable prognosis.
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